Japanese stem cell gene delivery breakthrough
This article was originally published in Scrip
In a breakthrough which could aid the development of drug screening models and regenerative therapies, Japanese researchers have used a helper-dependent adenoviral vector to deliver genes to human embryonic stem cells with an efficiency of close to 100%. Typical efficiency for non-viral vectors is around 50% and several percent only for normal viral vectors. Helper-dependent vectors lack all viral coding sequences, minimising immunogenicity compared with common adenoviral vectors. Efficient gene delivery to pluripotent stem cells may allow better induction and control of differentiation into various cell types. The findings from Professor Kohnosuke Mitaniet al were published in the proceedings of the US National Academy of Sciences.
You may also be interested in...
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.